Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2011 | 2017 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.030 | 1.000 | 3 | 2009 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.030 | 1.000 | 3 | 2009 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 3 | 159992214 | intron variant | A/C;T | snv |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Infections | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.030 | 1.000 | 3 | 2012 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders | 0.030 | 1.000 | 3 | 2012 | 2017 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Skin and Connective Tissue Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.649 | 0.600 | 3 | 159995680 | 3 prime UTR variant | G/A | snv | 0.16 |
|
Digestive System Diseases; Neoplasms | 0.030 | 0.667 | 3 | 2011 | 2017 | |||||||
|
0.776 | 0.320 | 3 | 159988493 | intron variant | T/G | snv | 0.10 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2016 |